Direkt zum Inhalt
Merck
  • Vasorelaxant activities of Danhong injection and their differential effects on the rat abdominal aorta and mesenteric artery.

Vasorelaxant activities of Danhong injection and their differential effects on the rat abdominal aorta and mesenteric artery.

Journal of cardiovascular pharmacology (2014-09-30)
Xianming Su, Xiaowen Zhi, Ting Cui, Qiaowei Zheng, Shixiang Wang, Yongxiao Cao, Changcong Cui, Weiyi Feng
ZUSAMMENFASSUNG

Previous studies have found that Danhong injection (DHI), an extensively used herbal extract preparation in China, might be a powerful vasodilator. The aims of this study were to determine the vascular activity of DHI and its effects on arteries of different sizes. The results showed that DHI significantly inhibited rat-hindquarters and rabbit-ear vasoconstriction elicited by norepinephrine (NE) perfusion and markedly relaxed KCl-contracted and NE-contracted rat abdominal aortic and mesenteric artery rings. The endothelium made only a minor contribution to the vasorelaxant effect of DHI on artery segments. The vasorelaxant effect of DHI varied with the artery size, with larger arteries exhibiting a more sensitive and potent vasodilator response. DHI relaxed NE-induced vasoconstriction probably through inhibition of the intracellular Ca2+ release through the inositol triphosphate receptor system in the abdominal aorta and mesenteric artery, along with blockage of extracellular Ca2+ influx through the receptor-linked Ca2+ channels in the mesenteric artery. In addition, DHI completely relaxed KCl-induced contraction in both of the arteries, suggesting that inhibition of Ca2+ influx through voltage-gated Ca2+ channels is involved in the vasorelaxant effect of DHI. This elucidation of the vascular effects of DHI and the underlying mechanisms could lead to improved clinical applications.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Triethylamin, BioUltra, ≥99.5% (GC)
Sigma-Aldrich
Koffein, anhydrous, 99%, FCC, FG
Sigma-Aldrich
4-Aminopyridin, 98%
Sigma-Aldrich
Triethylamin, ≥99.5%
USP
Koffein, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
4-Aminopyridin, ≥99%
Sigma-Aldrich
Koffein, powder, ReagentPlus®
Supelco
Koffein, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Triethylamin, ≥99%
Sigma-Aldrich
Atropin -sulfat (Salz) Monohydrat, ≥97% (TLC), crystalline
USP
Koffein-Schmelzpunkt-Standard, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Triethylamin, ≥99.5%
Sigma-Aldrich
Triethylamin, for protein sequence analysis, ampule, ≥99.5% (GC)
USP
Atropinsulfat, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Triethylamin, for amino acid analysis, ≥99.5% (GC)
Sigma-Aldrich
Triethylamin, puriss. p.a., ≥99.5% (GC)
Supelco
Coffein Schmelzpunktstandard, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Koffein, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
Koffein, Sigma Reference Standard, vial of 250 mg
Sigma-Aldrich
Acetylcholinbromid, ≥99%
Supelco
Atropinsulfat, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Schmelzpunktstandard 235-237°C, analytical standard
Supelco
Mettler Toledo Calibration Substance ME 18872, Caffeine, traceable to primary standards (LGC)
Sigma-Aldrich
Koffein, anhydrous, tested according to Ph. Eur.
Sigma-Aldrich
Phentolamin -methansulfonat (Salz), ≥98% (TLC), powder
Sigma-Aldrich
Koffein, meets USP testing specifications, anhydrous
Supelco
Triethylamin, analytical standard
Sigma-Aldrich
Koffein, BioXtra
Koffein für die Systemeignung, European Pharmacopoeia (EP) Reference Standard
Koffein, European Pharmacopoeia (EP) Reference Standard